Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A mechanism of self-lipid endocytosis mediated by the receptor Mincle.
Kostarnoy AV, Gancheva PG, Kireev II, Soloviev AI, Lepenies B, Kulibin AY, Malolina EA, Scheglovitova ON, Kondratev AV, Sokolova MV, Vorobyeva D, Filippova N, Kapkaeva MR, Lagarkova MA, Metalnikov PS, Riabenko E, Grumov DA, Bobrov MA, Vasilieva E, Naroditsky BS, Gintsburg AL. Kostarnoy AV, et al. Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2120489119. doi: 10.1073/pnas.2120489119. Epub 2022 Jul 22. Proc Natl Acad Sci U S A. 2022. PMID: 35867828 Free PMC article.
Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate.
Kostarnoy AV, Gancheva PG, Lepenies B, Tukhvatulin AI, Dzharullaeva AS, Polyakov NB, Grumov DA, Egorova DA, Kulibin AY, Bobrov MA, Malolina EA, Zykin PA, Soloviev AI, Riabenko E, Maltseva DV, Sakharov DA, Tonevitsky AG, Verkhovskaya LV, Logunov DY, Naroditsky BS, Gintsburg AL. Kostarnoy AV, et al. Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2758-E2765. doi: 10.1073/pnas.1611665114. Epub 2017 Mar 14. Proc Natl Acad Sci U S A. 2017. PMID: 28292894 Free PMC article.
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.
Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, Tukhvatulina NM, Shcheblyakov DV, Shmarov MM, Tokarskaya EA, Simakova YV, Egorova DA, Scherbinin DN, Tutykhina IL, Lysenko AA, Kostarnoy AV, Gancheva PG, Ozharovskaya TA, Belugin BV, Kolobukhina LV, Pantyukhov VB, Syromyatnikova SI, Shatokhina IV, Sizikova TV, Rumyantseva IG, Andrus AF, Boyarskaya NV, Voytyuk AN, Babira VF, Volchikhina SV, Kutaev DA, Bel'skih AN, Zhdanov KV, Zakharenko SM, Borisevich SV, Logunov DY, Naroditsky BS, Gintsburg AL. Dolzhikova IV, et al. Among authors: kostarnoy av. Hum Vaccin Immunother. 2017 Mar 4;13(3):613-620. doi: 10.1080/21645515.2016.1238535. Epub 2017 Feb 2. Hum Vaccin Immunother. 2017. PMID: 28152326 Free PMC article. Clinical Trial.